by Soft Tissue Repair refers to the reconstruction or restoration of defective soft tissues for restoring normal function. Soft tissues include muscles, tendons, ligaments and neural tissues. Soft tissue injuries can occur due to sports injuries, trauma injuries or burns. Conventional treatment approaches like autografts and allografts have certain limitations which has propelled the development of regenerative medicine approaches using growth factors, gene therapy and tissue engineering for soft tissue repair. The global Soft Tissue Repair Market is estimated to be valued at US$ 2164.02 Mn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Regenerative medicine approaches are gaining significant traction in soft tissue repair. Various tissue engineering techniques are being explored to develop graft substitutes by seeding cells on biodegradable scaffolds for repairing damaged tissues. For example, mesenchymal stem cells obtained from adipose tissues or bone marrow are being seeded on natural or synthetic scaffolds made of polymers, collagen or fibrin for cartilage, tendon or ligament regeneration applications. Growth factors and Gene therapy are also being investigated for promoting tissue regeneration by stimulating cell proliferation and extracellular matrix production. Industry players are collaborating with research institutes to advance technologies in 3D bioprinting of tissues as well. This is expected to propel the soft tissue repair market during the forecast period.
SWOT Analysis
Strength: The soft tissue repair market is growing due to the rising incidence of soft tissue injuries caused by accidents and sports injuries. The advancement in regeneration techniques is further fueling the market growth.
Weakness: High cost of soft tissue repair surgeries and longer recovery time post-surgery are some of the challenges faced by the market.
Opportunity: Increase in vascular injuries, technological advancements in tissue engineering for soft tissue repair, and rise in aging population are providing new growth opportunities.
Threats: Stringent regulations for new product approvals and risk of product failure are some of the threats faced by players in this market.
Key Takeaways
The Global Soft Tissue Repair Market Size is expected to witness high growth over the forecast period of 2023 to 2030.
Regional analysis: North America is expected to continue dominating the soft tissue repair market during the forecast period due to increasing obesity rates leading to orthopedic complications. The Asia Pacific region is anticipated to witness the fastest growth due to growing medical tourism, rising healthcare expenditure, and increasing geriatric population.
Key players: Key players operating in the soft tissue repair market are Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc. These players are focusing on new product launches and mergers & acquisitions to strengthen their market position.
*Note:
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it
